Prestige Wealth Management Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.87K | Sell |
|
|||||
|
2025
Q1 | $5.37K | Buy |
|
|||||
|
2024
Q4 | $2.23K | Sell |
|
|||||
|
2024
Q3 | $4.15K | Buy |
|
|||||
|
2024
Q2 | $2.8K | Sell |
|
|||||
|
2024
Q1 | $4.54K | Sell |
|
|||||
|
2023
Q4 | $11.2K | Buy |
|
|||||
|
2023
Q3 | $9.73K | Sell |
|
|||||
|
2023
Q2 | $11.9K | Hold |
|
|||||
|
2023
Q1 | $13.3K | Buy |
|
|||||
|
2022
Q4 | $13.5K | Buy |
|
|||||
|
2022
Q3 | $11K | Sell |
|
|||||
|
2022
Q2 | $19K | Buy |
|
|||||
|
2022
Q1 | $11K | Hold |
|
|||||
|
2021
Q4 | $13K | Hold |
|
|||||
|
2021
Q3 | $11K | Buy |
|
|||||
|
2021
Q2 | $11K | Buy |
|
|||||
|
2021
Q1 | $9K | Sell |
|
|||||
|
2020
Q4 | $12K | Buy |
|
|||||
|
2020
Q3 | $5K | Sell |
|
|||||
|
2020
Q2 | $16K | Buy |
|
|||||
|
2020
Q1 | $5K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $11K | Buy |
|